Literature DB >> 27123090

Bladder cancer in a young patient: Undiscovered risk factors.

Rafay Khan1, Hiyam Ibrahim1, Sunil Tulpule1, Nneka Iroka1.   

Abstract

Bladder cancer is one of the most common forms of malignancies involving the urinary system and multiple risk factors have been associated with its etiology. The most common of which include cigarette smoking and various occupational or chemical exposures. It is usually diagnosed in older individuals with an average age of 70. In rare cases it is observed in children as well as young adults where it usually presents as a low-grade, non-invasive disease. In the present case report a 27-year-old male patient is discussed: The patient presented with no significant risk factors and was treated for mucinous adenocarcinoma of the bladder while further investigations were performed to identify other associated factors related to this form of malignancy. Debate in the literature exists in regards to the characteristics of bladder neoplasms in younger patients compared with older patients, however there is a lack of research into the etiology or prognosis in young patients. The present case study illustrates the case of a young adult with no clear risk factors who was diagnosed with a rare case of mucinous adenocarcinoma of the bladder.

Entities:  

Keywords:  bladder cancer; mucinous adenocarcinoma; risk factors; young adult

Year:  2016        PMID: 27123090      PMCID: PMC4841098          DOI: 10.3892/ol.2016.4355

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  6 in total

1.  Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.

Authors:  Jung Ho Kim; Ye-Young Rhee; Jeong Mo Bae; Nam-Yun Cho; Gyeong Hoon Kang
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

2.  Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases.

Authors:  Melissa L Stanton; Li Xiao; Bogdan A Czerniak; Charles C Guo
Journal:  Arch Pathol Lab Med       Date:  2013-10       Impact factor: 5.534

3.  A male presenting with a primary mucinous bladder carcinoma: a case report.

Authors:  Konstantinos Sigalas; Stavros I Tyritzis; Eleni Trigka; Ioannis Katafigiotis; Nikolaos Kavantzas; Konstantinos G Stravodimos
Journal:  Cases J       Date:  2010-02-03

4.  Mucinous adenocarcinoma with superficial stromal invasion and villous adenoma of urachal remnants: a case report.

Authors:  R Mazzucchelli; M Scarpelli; R Montironi
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

5.  Occupation and bladder cancer among men in Western Europe.

Authors:  Manolis Kogevinas; Andrea 't Mannetje; Sylvaine Cordier; Ulrich Ranft; Carlos A González; Paolo Vineis; Jenny Chang-Claude; Elsebeth Lynge; Jürgen Wahrendorf; Anastasia Tzonou; Karl-Heinz Jöckel; Consol Serra; Stefano Porru; Martine Hours; Eberhard Greiser; Paolo Boffetta
Journal:  Cancer Causes Control       Date:  2003-12       Impact factor: 2.506

6.  Risk of urinary bladder cancer: a case-control analysis of industry and occupation.

Authors:  Adrian Cassidy; Wei Wang; Xifeng Wu; Jie Lin
Journal:  BMC Cancer       Date:  2009-12-15       Impact factor: 4.430

  6 in total
  2 in total

1.  Somatic Mutations Profile of a Young Patient With Metastatic Urothelial Carcinoma Reveals Mutations in Genes Involved in Ion Channels.

Authors:  Jyoti Sharma; Barnali Deb; Irene A George; Shruthi Kapil; Karunakaran Coral; Nandita Kakkar; Smita Pattanaik; Arup Kumar Mandal; Ravimohan S Mavuduru; Prashant Kumar
Journal:  Front Oncol       Date:  2019-05-29       Impact factor: 6.244

2.  Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target.

Authors:  Ming Sun; Wenyan Zhao; Yuecan Zeng; Di Zhang; Zhaofu Chen; Caigang Liu; Bin Wu
Journal:  Onco Targets Ther       Date:  2017-08-07       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.